In particular, endoradiotherapy with the small molecule PSMA-inhibitor PSMA-617 labeled with alpha emitters was reported to have the potential of complete remission in advanced stage prostate cancer patients [27]. The gene discussed is FOLH1; the disease is prostate cancer.